公司财务指标分析

Search documents
Compared to Estimates, Vail Resorts (MTN) Q4 Earnings: A Look at Key Metrics
ZACKS· 2025-09-29 23:01
Vail Resorts (MTN) reported $271.29 million in revenue for the quarter ended July 2025, representing a year-over-year increase of 2.2%. EPS of -$5.08 for the same period compares to -$4.67 a year ago.The reported revenue represents a surprise of -0.21% over the Zacks Consensus Estimate of $271.87 million. With the consensus EPS estimate being -$4.75, the EPS surprise was -6.95%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determ ...
Hormel (HRL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-08-28 14:30
For the quarter ended July 2025, Hormel Foods (HRL) reported revenue of $3.03 billion, up 4.6% over the same period last year. EPS came in at $0.35, compared to $0.37 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $2.98 billion, representing a surprise of +1.9%. The company delivered an EPS surprise of -14.63%, with the consensus EPS estimate being $0.41.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expe ...
兴蓉环境(000598.SZ):2025年中报净利润为9.75亿元、同比较去年同期上涨5.03%
Xin Lang Cai Jing· 2025-08-28 02:28
Core Insights - The company reported a total operating revenue of 4.192 billion yuan, ranking 4th among disclosed peers, with a year-on-year increase of 184 million yuan, marking a 4.59% growth compared to the same period last year [1] - The net profit attributable to shareholders reached 975 million yuan, ranking 2nd among disclosed peers, with an increase of 46.71 million yuan, reflecting a 5.03% year-on-year growth [1] - The net cash inflow from operating activities was 934 million yuan, ranking 5th among disclosed peers [1] Financial Ratios - The latest debt-to-asset ratio is 58.58%, a decrease of 0.41 percentage points from the previous quarter and a decrease of 0.86 percentage points from the same period last year [3] - The latest gross profit margin is 45.62%, ranking 7th among disclosed peers, with an increase of 2.54 percentage points year-on-year [3] - The latest return on equity (ROE) is 5.22%, ranking 15th among disclosed peers [3] Earnings Per Share and Turnover - The diluted earnings per share is 0.33 yuan, ranking 22nd among disclosed peers, with an increase of 0.02 yuan, reflecting a 4.91% year-on-year growth [3] - The latest total asset turnover ratio is 0.09 times, while the inventory turnover ratio is 9.80 times, ranking 21st among disclosed peers, with a year-on-year increase of 0.18 times [3] Shareholder Structure - The number of shareholders is 60,700, with the top ten shareholders holding 1.902 billion shares, accounting for 63.73% of the total share capital [3] - The largest shareholder is Chengdu Environmental Investment Group Co., Ltd., holding 42.21% of the shares [3]
Heico (HEI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-08-25 23:31
Core Insights - Heico Corporation reported $1.15 billion in revenue for the quarter ended July 2025, marking a year-over-year increase of 15.7% and exceeding the Zacks Consensus Estimate of $1.11 billion by 3.06% [1] - The company achieved an EPS of $1.26, up from $0.97 a year ago, resulting in an EPS surprise of 12.5% compared to the consensus estimate of $1.12 [1] Financial Performance Metrics - Net Sales for the Electronic Technologies Group (ETG) reached $355.86 million, surpassing the four-analyst average estimate of $346.93 million, with a year-over-year change of 10.5% [4] - Net Sales for the Flight Support Group (FSG) totaled $802.66 million, exceeding the four-analyst average estimate of $780.64 million, reflecting a year-over-year increase of 17.8% [4] - Net Sales for Corporate & Intersegment reported at -$10.93 million, better than the three-analyst average estimate of -$12.72 million, showing a year-over-year change of -5% [4] - Operating income for the Flight Support Group was $198.33 million, above the three-analyst average estimate of $184.62 million [4] - Operating income for Electronic Technologies Group was $81 million, below the three-analyst average estimate of $87.72 million [4] - Operating income for Other, primarily corporate, was -$14.31 million, better than the average estimate of -$19.9 million by three analysts [4] Stock Performance - Heico's shares have returned -4.4% over the past month, contrasting with the Zacks S&P 500 composite's +2.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]
Compared to Estimates, Alcon (ALC) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-08-19 23:31
Core Insights - Alcon reported revenue of $2.58 billion for Q2 2025, a year-over-year increase of 3.8% and an EPS of $0.76, up from $0.74 a year ago [1] - The revenue fell short of the Zacks Consensus Estimate of $2.61 billion by 1.29%, while the EPS exceeded the consensus estimate of $0.71 by 7.04% [1] Financial Performance Metrics - Alcon's stock has returned +1.1% over the past month, underperforming the Zacks S&P 500 composite's +2.5% change [3] - The company holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3] Regional Sales Performance - International net sales were $1.42 billion, slightly below the estimated $1.45 billion, reflecting a year-over-year increase of +5.7% [4] - U.S. net sales reached $1.16 billion, compared to the estimated $1.18 billion, marking a +1.7% year-over-year change [4] Segment Sales Performance - Total Surgical net sales were $1.46 billion, below the estimated $1.48 billion, with a year-over-year increase of +2.3% [4] - Total Vision Care net sales were $1.12 billion, slightly below the estimated $1.13 billion, showing a +6% year-over-year change [4] - Total Surgical Consumables sales were $777 million, compared to the average estimate of $786.91 million, reflecting a +5.6% year-over-year change [4] - Total Surgical Equipment/Other sales were $222 million, below the estimated $232.7 million, with a -0.5% year-over-year change [4] - Total Vision Care Contact Lenses sales were $692 million, exceeding the estimated $682.51 million, with an +8.8% year-over-year change [4] - Total Vision Care Ocular Health sales were $430 million, below the estimated $446.4 million, reflecting a +1.7% year-over-year change [4] - Total Surgical Implantables sales were $456 million, slightly below the estimated $464.21 million, with a -1.7% year-over-year change [4] - Other revenues were reported at $19 million, exceeding the estimated $17.22 million, with a significant +35.7% year-over-year change [4]
宝莱特(300246.SZ):2025年中报净利润为131.34万元,同比扭亏为盈
Xin Lang Cai Jing· 2025-08-18 02:05
Core Insights - Baolite (300246.SZ) reported a total operating revenue of 523 million yuan for the first half of 2025, with a net profit attributable to shareholders of 1.3134 million yuan, an increase of 3.8284 million yuan compared to the same period last year [1] Financial Performance - The company's operating cash flow showed a net outflow of 24.7465 million yuan, which is an improvement of 13.6225 million yuan compared to the same period last year [1] - The latest debt-to-asset ratio stands at 46.18%, a decrease of 1.17 percentage points from the same period last year [3] - The gross profit margin is reported at 25.50% [3] - Return on equity (ROE) is at 0.11%, an increase of 0.30 percentage points year-on-year [3] - The diluted earnings per share (EPS) is 0.01 yuan, an increase of 0.01 yuan compared to the same period last year [3] - The total asset turnover ratio is 0.21 times, remaining stable compared to the same period last year, with a year-on-year increase of 1.91% [3] - The inventory turnover ratio is reported at 1.62 times [3] Shareholder Structure - The number of shareholders is 18,400, with the top ten shareholders holding a total of 92.17 million shares, accounting for 34.84% of the total share capital [3] - The largest shareholder, Yan Jinyuan, holds 26.72% of the shares [3] - Other notable shareholders include Wang Shi (2.46%) and Shenzhen Qianhai Jiuyin Investment Fund Management Co., Ltd. (1.37%) [3]
Here's What Key Metrics Tell Us About Red Robin (RRGB) Q2 Earnings
ZACKS· 2025-08-13 23:01
Core Insights - Red Robin (RRGB) reported revenue of $283.7 million for the quarter ended June 2025, reflecting a year-over-year decline of 5.5% [1] - The EPS for the same period was $0.26, a significant improvement from -$0.48 a year ago, resulting in an EPS surprise of +204% compared to the consensus estimate of -$0.25 [1] Financial Performance - The reported revenue was a slight miss, with a surprise of -0.53% against the Zacks Consensus Estimate of $285.22 million [1] - Comparable restaurant revenue showed a year-over-year change of -3.2%, which was below the estimated increase of 1.7% by analysts [4] - Total number of restaurants remained stable at 487, with 90 franchised and 397 company-owned, aligning with analyst estimates [4] Market Performance - Over the past month, shares of Red Robin have returned +5.8%, outperforming the Zacks S&P 500 composite's +3.1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]
Compared to Estimates, Aquestive Therapeutics (AQST) Q2 Earnings: A Look at Key Metrics
ZACKS· 2025-08-12 00:31
Core Insights - Aquestive Therapeutics reported $10 million in revenue for Q2 2025, a year-over-year decline of 50.2% [1] - The EPS for the same period was -$0.14, compared to -$0.03 a year ago, with a surprise of +22.22% against the consensus estimate of -$0.18 [1] Revenue Breakdown - Manufacture and supply revenue was $9.58 million, exceeding the average estimate of $8.49 million, representing an 18% year-over-year increase [4] - License and royalty revenue was $0.84 million, significantly below the estimated $2.09 million, reflecting a 92.5% decline compared to the previous year [4] - Co-development and research fees amounted to $0.38 million, slightly below the estimated $0.5 million, marking a 50% decrease year-over-year [4] Stock Performance - Shares of Aquestive Therapeutics have returned -2.7% over the past month, contrasting with the Zacks S&P 500 composite's +2.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]
Here's What Key Metrics Tell Us About Sweetgreen (SG) Q2 Earnings
ZACKS· 2025-08-08 19:30
Financial Performance - For the quarter ended June 2025, Sweetgreen, Inc. reported revenue of $185.58 million, which is an increase of 0.5% year-over-year [1] - The earnings per share (EPS) was -$0.20, compared to -$0.13 in the same quarter last year [1] - The reported revenue was a surprise of -3.11% compared to the Zacks Consensus Estimate of $191.54 million [1] - The EPS surprise was -66.67% against the consensus estimate of -$0.12 [1] Key Metrics - Same-store sales decreased by 7.6%, which was worse than the five-analyst average estimate of -5.3% [4] - The number of ending restaurants was 260, slightly above the five-analyst average estimate of 256 [4] - New restaurant openings totaled 9, exceeding the average estimate of 5 based on four analysts [4] Stock Performance - Sweetgreen's shares have returned -7.7% over the past month, while the Zacks S&P 500 composite increased by 1.9% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]
Xponential Fitness (XPOF) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-08-08 00:30
Core Insights - Xponential Fitness reported revenue of $76.21 million for the quarter ended June 2025, reflecting a year-over-year decline of 0.4% and an EPS of $0.26 compared to -$0.03 a year ago, indicating a significant improvement in profitability [1] - The revenue fell short of the Zacks Consensus Estimate of $77.16 million by 1.23%, while the EPS exceeded the consensus estimate of $0.19 by 36.84% [1] Financial Performance Metrics - Same store sales were reported at 1%, significantly lower than the estimated 3.9% by analysts [4] - Franchise revenue was $45.35 million, slightly below the average estimate of $45.58 million, but showed a year-over-year increase of 5.4% [4] - Franchise marketing fund revenue reached $9.46 million, surpassing the $9.32 million estimate, with a year-over-year growth of 12.9% [4] - Merchandise revenue was $5.61 million, slightly above the estimate of $5.56 million, but represented a year-over-year decline of 4.6% [4] - Other service revenue was $6.27 million, close to the estimated $6.29 million, showing a minor year-over-year decrease of 0.6% [4] - Equipment revenue was reported at $9.51 million, below the $9.77 million estimate, marking a significant year-over-year decline of 26.4% [4] Stock Performance - Xponential Fitness shares have returned +3.6% over the past month, outperforming the Zacks S&P 500 composite's +1.2% change [3] - The stock currently holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the broader market in the near term [3]